Parkinson’s UK invests £2.1 million in Neumora Therapeutics for preclinical testing of new Parkinson’s drug
Parkinson’s UK is investing £2.1million to support Neumora Therapeutics to carry out preclinical testing of NMRA-NLRP3, a NLRP3 inhibitor with ...
;Resize=(1200,627)&impolicy=perceptual&quality=mediumHigh&hash=7301bd0e744e9134d3fd975d455c17ea866a0e12edae91d3a8ac820e58bf1b4c "Tanken – Neue Regeln für Autofahrer gelten schon ab April")
